Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
PaperCitations, authors & open-access status
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 75 citations, 2019 year and gold oa status.
75
Citations
2019
Year
gold
OA Status